In the future, we will investigate which BB is to be preferred for the management of LQTS patients with increased risk factors, such as QTc > 500 ms, male gender in pre-puberty, female gender in adulthood, and LQT2/LQT3 genotypes. The gene discussed is SCN5A; the disease is familial long QT syndrome.